Sheldon Sloan, Chief Medical Officer: Spyre Therapeutics SYRE Planned sale · Filed 06/03

Trade details

Type: Planned sale notice
Stock: Spyre Therapeutics SYRE
Person: Sheldon SloanChief Medical Officer
Planned sale date: 26/06/03
Filed: 26/06/03

More to sell after $6M in 3 months

Spyre Therapeutics trades, last 26 weeks

What else happened in Spyre Therapeutics around then

Filed or reported within 30 days of the trade day · 05/04~07/03

Sheldon Sloan's recent trades

Sheldon SloanChief Medical Officer
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$625K
8,333 sh
$625K
Filed 06/03
Traded 06/03
Sheldon SloanChief Medical Officer
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$1.5M
21,306 sh
$1.5M
Filed 05/01
Traded 05/01
Sheldon SloanChief Medical Officer
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$1.4M
19,656 sh
$1.4M
Filed 05/01
Traded 05/01
Sheldon SloanChief Medical Officer
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$932K
12,777 sh
$932K
Filed 05/01
Traded 05/01
Sheldon SloanChief Medical Officer
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$763.8K
10,358 sh
$763.8K
Filed 05/01
Traded 05/01

Sheldon Sloan, Chief Officer — plans to sell 16,667 sh of Spyre Therapeutics SYRE · $1.2M · around 06/03 · 10b5-1 plan | Whalegun